CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 226 enrolled
Drug / intervention
nicotine +1 morecombination
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03262233
NCT03262233Phase 4Completed
CompareCT.gov

Clinical Relevance of Stress Neuroadaptation in Tobacco Dependence

University of Wisconsin, Madison·interventional·Posted Aug 25, 2017·Updated Apr 23, 2019

In Brief

A Phase 4 clinical trial evaluating nicotine and placebo for Nicotine Dependence. Completed, enrolled 226 participants across 1 site.

Detailed Summary

The objective of the current study is to evaluate the validity of the No Shock, Predictable Shock, Unpredictable Shock (NPU) stressor task for use as a surrogate endpoint to predict short-term clinical outcomes among smokers during a smoking cessation attempt.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNicotine Dependence
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 25, 2017
Enrollment StartApr 1, 2015
Primary CompletionFeb 20, 2018
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 8.9 years ago

Interventions

nicotinecombination

placeboother